Litronesib Racemate structure
|
Common Name | Litronesib Racemate | ||
---|---|---|---|---|
CAS Number | 546111-97-1 | Molecular Weight | 511.701 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C23H37N5O4S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Litronesib RacemateLitronesib (Racemate) is the racemate of litronesib. Litronesib is a selective, allosteric inhibitor of Eg5. |
Name | Litronesib Racemate |
---|---|
Synonym | More Synonyms |
Description | Litronesib (Racemate) is the racemate of litronesib. Litronesib is a selective, allosteric inhibitor of Eg5. |
---|---|
Related Catalog | |
References |
[1]. THERAPEUTIC AGENT FOR GLAUCOMA. Japanese Patent JP2006265107 |
Density | 1.2±0.1 g/cm3 |
---|---|
Molecular Formula | C23H37N5O4S2 |
Molecular Weight | 511.701 |
Exact Mass | 511.228699 |
LogP | 2.56 |
Index of Refraction | 1.587 |
Storage condition | 2-8℃ |
Propanamide, N-[4-(2,2-dimethyl-1-oxopropyl)-5-[[[[2-(ethylamino)ethyl]sulfonyl]amino]methyl]-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl- |
Litronesib |
N-{4-(2,2-Dimethylpropanoyl)-5-[({[2-(ethylamino)ethyl]sulfonyl}amino)methyl]-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl}-2,2-dimethylpropanamide |
Litronesib (Racemate) |